Provided by Tiger Trade Technology Pte. Ltd.

HARBOR HEALTH CARE ETF

34.95
+0.18100.52%
Volume:6K
Turnover:223.97K
Market Cap:44.56M
PE:- -
High:35.10
Open:35.10
Low:34.85
Close:34.77
52wk High:35.61
52wk Low:27.36
Shares:1.28M
Float Shares:1.28M
Volume Ratio:1.71
T/O Rate:0.50%
Dividend:0.08
Dividend Rate:0.22%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly & Co (LLY) Gets a Buy from Barclays

TIPRANKS
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Ascendis Pharma (ASND)

TIPRANKS
·
Aug 14

Ascendis Pharma a/S : Jefferies Raises Target Price to $333 from $325

THOMSON REUTERS
·
Aug 14

Analysts Are Bullish on These Healthcare Stocks: ProMIS Neurosciences (PMN), Ascendis Pharma (ASND)

TIPRANKS
·
Aug 14

Sands Capital boosts Eli Lilly stake with 12,445 shares

TIPRANKS
·
Aug 14

'It Feels Like a Medical Miracle': How Did a Single QR Code Coupon Cut My $618 Walgreens Prescription to $15?

Dow Jones
·
Aug 14

Assembly Bio Releases Corporate Deck Highlighting Clinical-Stage Pipeline, Gilead-Partnered HSV Program

Reuters
·
Aug 14

Celcuity Posts Narrower-than-Expected Loss as R&D Costs Decreased

Reuters
·
Aug 14

Assembly Biosciences Q2 Net Loss Narrows as Revenue Rises

Reuters
·
Aug 14

Aktis Oncology Q2 FY26 Net Loss Widens 33.15% to $24.1 Million

Reuters
·
Aug 14

Ascendis Pharma's Long-Term Potential Intact, Wedbush Says

MT Newswires Live
·
Aug 14

European Equities Traded in the US Rise in Thursday Trading

MT Newswires Live
·
Aug 13

Your Prescription Drugs Shouldn't Cost More than Your Mortgage. Inside the Broken Math That Got US Here.

Dow Jones
·
Aug 13

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly (LLY)

TIPRANKS
·
Aug 13

Ascendis Pharma A/S Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Sector Update: Healthcare Stocks Advance Pre-Bell Thursday

MT Newswires Live
·
Aug 13

Ascendis Pharma's Q2 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
Aug 13

CorMedix Beats Q2 Revenue Estimates on DefenCath Growth, Raises FY Adjusted Ebitda Guidance

Reuters
·
Aug 13

Ascendis Pharma Q2 Revenue EUR 339.3 Million

THOMSON REUTERS
·
Aug 13

Ascendis Pharma Q2 FY26 Swings to Net Profit of €207 Million; Revenue More than Doubles to €339 Million

Reuters
·
Aug 13